Opoku, Y. K., Liu, Z., Afrifa, J., Kumi, A. K., Liu, H., Ghartey-Kwansah, G., … Li, D. (2020). Fibroblast Growth Factor–21 ameliorates hepatic encephalopathy by activating the STAT3-SOCS3 pathway to inhibit activated hepatic stellate cells. EXCLI Journal, 19, 567–581. https://doi.org/10.17179/excli2020-1287